Lieberman Linda A, Tsokos George C
Division of Rheumatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, CLS 937, Boston, MA 02115, USA.
J Biomed Biotechnol. 2010;2010:740619. doi: 10.1155/2010/740619. Epub 2010 Jun 6.
IL-2 production is decreased in systemic lupus erythematosus (SLE) patients and affects T cell function and other aspects of host immunity. Transcription factors regulating IL-2 production behave aberrantly in SLE T cells. In addition to IL-2 dysregulation, other IL-2 family members (IL-15 and IL-21) are abnormally expressed in SLE. Decreased IL-2 production in SLE patients leads to many immune defects such as decreased T(reg) production, decreased activation-induced cell death (AICD), and decreased cytotoxicity. IL-2 deficiency results in systemic dysregulation of host immune responses in patients suffering from SLE disease.
系统性红斑狼疮(SLE)患者的白细胞介素-2(IL-2)产生减少,这会影响T细胞功能及宿主免疫的其他方面。调节IL-2产生的转录因子在SLE T细胞中表现异常。除了IL-2失调外,其他IL-2家族成员(IL-15和IL-21)在SLE中也异常表达。SLE患者IL-2产生减少会导致许多免疫缺陷,如调节性T细胞(T(reg))产生减少、活化诱导的细胞死亡(AICD)减少以及细胞毒性降低。IL-2缺乏导致SLE疾病患者宿主免疫反应的系统性失调。